The use of immunotherapy to treat metastatic breast cancer – Brinkwire – Brinkwire (press release)
|
The use of immunotherapy to treat metastatic breast cancer – Brinkwire
Brinkwire (press release) Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10% (1). Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harbouring the expression … |
